Wetter Pharma-Fertigung GmbH & Co KG (manufacturing of unpackaged products, primary packaging, in-process control, testing for sterility and bacterial endotoxins; testing for sterility and bacterial endotoxins, visual inspection during manufacturing)

Ukraine

All drugs from this manufacturer

  • ACTEMRA

    The drug is prescribed for the treatment of rheumatoid arthritis (in adults), polyarticular juvenile idiopathic arthritis (in children from 2 years of age), giant cell arteritis (in adults), and systemic juvenile idiopathic arthritis (in children from 1 year of age).

    Dosage form: solution for injection

    Active substance Dosage
    tocilizumab 162 mg/0.9 mL

    ATC: L04AC07